查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1455224

2024年药物释放型球囊导管全球市场报告

Drug Eluting Balloons Catheters Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

药物释放型球囊导管的市场规模预计在未来几年将快速成长。预计到 2028 年将以 13.2% 的复合年增长率 (CAGR) 增长至 23.5 亿美元。预测期内的预期增长是由呼吸系统疾病的持续增加、老年人口的增加、呼吸系统健康意识和教育的提高、新兴国家的市场扩张、定製配方的开发以及监管、支持和合规以及包装推动的。以及吸入器产业的设计创新。预测期内预计的主要趋势包括智慧吸入器和连接的出现、向呼吸驱动吸入器的转变、注重满​​足儿童和老年患者的需求、生技药品输送的进步，其中包括开发环保吸入器设计。

週边血管疾病和心血管疾病盛行率的预期增加预计将推动未来药物释放型球囊导管市场的成长。心血管疾病 (CVD) 包括影响心臟和循环系统的多种疾病，周边动脉疾病(PAD) 特别涉及动脉狭窄，从而减少流向手臂和腿部的血液。药物释放型球囊导管是冠状动脉疾病 (CAD) 的治疗方法，采用涂有抗增殖物质的半相容球囊，在进入血管后提供抗血管再阻塞作用。例如，2023年4月，英国心臟基金会报告称，英国死于心臟疾病的人数已从2020年的64,170人增加到2021年的65,579人。此外，HMP World预测，到2030年，美国患有周边动脉疾病的人数将达到2,380万人。因此，週边血管疾病和心血管疾病的盛行率日益增加正在推动药物释放型球囊导管市场的发展。

对微创手术的需求不断增长预计将进一步推动药物释放型球囊导管市场的成长。微创手术涉及涉及小切口的手术技术，从而缩短癒合时间、减少疼痛并降低感染风险。药物释放型球囊在这些手术中至关重要，可将药物直接输送到治疗区域，以防止血管再阻塞并提高血管介入治疗的有效性。例如，Intuitive Surgical Inc. 报告称，使用其 Vinci 手术系统的外科手术数量增加了 18%，从 2021 年的 1,594,000 例增加到 2022 年的 1,875,000 例。此外，美国整形外科医师协会指出，美国的美容微创手术数量已增加至 23,672,269 例。因此，对微创手术的需求不断增长正在推动药物释放型球囊导管市场的成长。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球药物释放型球囊导管市场驱动因素与限制因素
    • 市场驱动力
    • 市场限制
  • 2018-2023年全球药物释放型球囊导管市场规模、表现与成长
  • 2023-2028、2033年全球药物释放型球囊导管市场规模及成长预测

第六章市场区隔

  • 全球药物释放型球囊导管市场，依产品、性能及预测细分，2018-2023、2023-2028、2033
  • 用于冠状动脉疾病的药物释放型球囊导管
  • 用于週边血管疾病的药物释放型球囊导管
  • 全球药物释放型球囊导管市场，依药物细分、性能及预测，2018-2023、2023-2028、2033
  • 紫杉醇
  • Sirolimus
  • 其他药品
  • 全球药物释放型球囊导管市场，依原料、性能及预测细分，2018-2023、2023-2028、2033
  • 尼龙
  • 聚氨酯
  • 其他原料
  • 全球药物释放型球囊导管市场，依最终用户细分、性能和预测，2018-2023、2023-2028、2033
  • 医院和诊所
  • 门诊手术中心
  • 导尿实验室

第 7 章 区域与国家分析

  • 全球药物释放型球囊导管市场，按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球药物释放型球囊导管市场，依国家、地区、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 药物洗脱球囊导管市场竞争格局
  • 药物洗脱球囊导管市场公司概况
    • Abbott Laboratories
    • Medtronic PLC
    • Becton Dickinson and Company
    • Koninklijke Philips NV
    • Boston Scientific Corporation

第三十一章 其他重大及创新企业

  • B Braun Melsungen Aktiengesellschaft
  • Terumo Corporation
  • Cook Medical LLC
  • Lepu Medical Technology Co. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • BIOTRONIK SE &Co. KG
  • Acotec Scientific Co. Ltd.
  • Cordis Corporation
  • Biosensors International Group Ltd.
  • Zylox-Tonbridge Medical Technology Co. Ltd.
  • Mermaid Medical AS
  • Hexacath Limited
  • Zhejiang Barty Medical Technology Co. Ltd.
  • Cardionovum GmbH

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r16225

A drug-eluting balloon catheter is a medical device utilized in the treatment of coronary artery disease through percutaneous coronary intervention (PCI). It is a semi-compliant angioplasty balloon that is coated with an anti-proliferative drug. During inflation, the drug is released into the vessel wall, aiming to prevent restenosis and reduce the risk of late thrombosis without the need for implanting a permanent foreign object.

The main types of drug-eluting balloon catheters include those designed for coronary artery disease and peripheral vascular disease. Coronary artery disease drug-eluting balloon catheters deliver antiproliferative drugs directly to the vessel wall using a lipophilic matrix, eliminating the need for a permanent structure such as a metal prosthesis or persistent polymer. Various drugs such as paclitaxel and sirolimus are used, and the catheters are made from raw materials such as nylon, polyurethane, and others. They find applications in hospitals, clinics, ambulatory surgical centers, and catheterization laboratories.

The drug eluting balloons catherers market research report is one of a series of new reports from The Business Research Company that provides drug eluting balloons catherers market statistics, including drug eluting balloons catherers industry global market size, regional shares, competitors with a drug eluting balloons catherers market share, detailed drug eluting balloons catherers market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting balloons catherers industry. This drug eluting balloons catherers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug eluting balloons catheters market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.43 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth observed in the historical period can be attributed to factors such as the increasing prevalence of respiratory disorders, the advantages offered over traditional inhalers, patient preferences for dry powder inhalers (DPIs), government initiatives for respiratory health, strategic collaborations and partnerships in the healthcare sector, advancements in drug formulations, and the rising geriatric population.

The drug eluting balloons catheters market size is expected to see rapid growth in the next few years. It will grow to $2.35 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The anticipated growth in the forecast period can be attributed to the ongoing increase in respiratory disorders, the expanding geriatric population, rising awareness and education regarding respiratory health, market expansion in emerging economies, the development of customized drug formulations, regulatory support and compliance, and innovations in packaging and design within the inhaler industry. Major trends expected in the forecast period include the emergence of smart inhalers and connectivity, a shift towards breath-actuated inhalers, a focus on meeting the needs of pediatric and geriatric patients, advancements in biologics delivery, and the development of environmentally friendly inhaler designs.

The anticipated rise in the prevalence of peripheral and cardiovascular diseases is set to drive the growth of the drug-eluting balloon catheter market in the future. Cardiovascular diseases (CVDs) encompass a range of conditions affecting the heart and circulatory system, while peripheral artery disease (PAD) specifically involves narrowed arteries reducing blood flow to the arms or legs. Drug-eluting balloon catheters, a treatment for coronary artery disease (CAD), employ a semi-compliant angioplasty balloon coated with an anti-proliferative substance, providing an anti-restenotic effect upon entering the vessel. For example, in April 2023, the British Heart Foundation reported a rise in coronary heart disease deaths in the UK from 64,170 in 2020 to 65,579 in 2021. Additionally, HMP Global projected that peripheral arterial disease prevalence in the US would reach 23.8 million by 2030, up from 21.0 million in 2020. Hence, the growing prevalence of peripheral and cardiovascular diseases is a driving force behind the drug-eluting balloon catheter market.

The increasing demand for minimally invasive procedures is expected to further propel the growth of the drug-eluting balloon catheter market. Minimally invasive procedures involve surgical techniques with small incisions, resulting in reduced healing time, less pain, and lower infection risks. Drug-eluting balloons are crucial in these procedures, delivering medication directly to the treatment area to prevent restenosis and enhance the effectiveness of vascular interventions. For instance, Intuitive Surgical Inc. reported an 18% increase in surgical procedures using Vinci surgical systems from 1,594,000 in 2021 to 1,875,000 in 2022. Additionally, the American Society of Plastic Surgeons noted a rise in cosmetic minimally invasive procedures in the US to 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the drug-eluting balloon catheter market.

The negative impact of adverse effects associated with the treatment hindered the growth of the drug-eluting balloon catheter market during the historic period. While drug-eluting balloons present a promising treatment for coronary artery disease, careful consideration is necessary due to potential side effects. Medtronic PLC highlighted potential complications, including balloon rupture, detachment of components, failure to perform as intended, and failure to cross the lesion during peripheral balloon catheterization. Hence, adverse effects can negatively impact the growth of the drug-eluting balloon catheter market.

Major companies in the drug-eluting balloon catheter market are intensifying their focus on developing next-generation products with advanced technologies to gain a competitive edge. For instance, Medtronic PLC launched Prevail DCB in Europe in July 2021, the latest-generation drug-coated balloon catheter for treating coronary artery disease. Integrating paclitaxel, a quickly absorbed drug, and PowerTrac technology from Medtronic Resolute Onyx DES delivery system, Prevail DCB offers superior deliverability and pushing power in PCI procedures.

In June 2023, Translumina Therapeutics Company acquired Blue Medical Devices BV for an undisclosed amount. This strategic acquisition aimed to integrate Blue Medical's unique drug application technology into Translumina's product lines, expanding offerings in neurovascular and peripheral interventions and enhancing drug coating capabilities. Blue Medical Devices BV is a Netherlands-based medical device company specializing in producing drug-eluting balloon catheters.

Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB.

North America was the largest region in the drug eluting balloons catheters market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug-eluting balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug-eluting balloon catheter market consists of sales of everolimus and stellarex. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Eluting Balloons Catheters Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug eluting balloons catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug eluting balloons catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug eluting balloons catheters market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters; Peripheral Vascular Disease Drug-Eluting Balloon Catheters
  • 2) By Drug: Paclitaxel; Sirolimus; Other Drugs
  • 3) By Raw Material: Nylon; Polyurethane; Other Raw Materials
  • 4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Catheterization Laboratories
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Becton Dickinson and Company; Koninklijke Philips NV; Boston Scientific Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Eluting Balloons Catheters Market Characteristics

3. Drug Eluting Balloons Catheters Market Trends And Strategies

4. Drug Eluting Balloons Catheters Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Drug Eluting Balloons Catheters Market Size and Growth

  • 5.1. Global Drug Eluting Balloons Catheters Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drug Eluting Balloons Catheters Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drug Eluting Balloons Catheters Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Eluting Balloons Catheters Market Segmentation

  • 6.1. Global Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Coronary Artery Disease Drug-Eluting Balloon Catheters
  • Peripheral Vascular Disease Drug-Eluting Balloon Catheters
  • 6.2. Global Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Paclitaxel
  • Sirolimus
  • Other Drugs
  • 6.3. Global Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Nylon
  • Polyurethane
  • Other Raw Materials
  • 6.4. Global Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Surgical Centers
  • Catheterization Laboratories

7. Drug Eluting Balloons Catheters Market Regional And Country Analysis

  • 7.1. Global Drug Eluting Balloons Catheters Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drug Eluting Balloons Catheters Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Eluting Balloons Catheters Market

  • 8.1. Asia-Pacific Drug Eluting Balloons Catheters Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Eluting Balloons Catheters Market

  • 9.1. China Drug Eluting Balloons Catheters Market Overview
  • 9.2. China Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Eluting Balloons Catheters Market

  • 10.1. India Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Eluting Balloons Catheters Market

  • 11.1. Japan Drug Eluting Balloons Catheters Market Overview
  • 11.2. Japan Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Eluting Balloons Catheters Market

  • 12.1. Australia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Eluting Balloons Catheters Market

  • 13.1. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Eluting Balloons Catheters Market

  • 14.1. South Korea Drug Eluting Balloons Catheters Market Overview
  • 14.2. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Eluting Balloons Catheters Market

  • 15.1. Western Europe Drug Eluting Balloons Catheters Market Overview
  • 15.2. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Eluting Balloons Catheters Market

  • 16.1. UK Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Eluting Balloons Catheters Market

  • 17.1. Germany Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Eluting Balloons Catheters Market

  • 18.1. France Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Eluting Balloons Catheters Market

  • 19.1. Italy Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Eluting Balloons Catheters Market

  • 20.1. Spain Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Eluting Balloons Catheters Market

  • 21.1. Eastern Europe Drug Eluting Balloons Catheters Market Overview
  • 21.2. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Eluting Balloons Catheters Market

  • 22.1. Russia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Eluting Balloons Catheters Market

  • 23.1. North America Drug Eluting Balloons Catheters Market Overview
  • 23.2. North America Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Eluting Balloons Catheters Market

  • 24.1. USA Drug Eluting Balloons Catheters Market Overview
  • 24.2. USA Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Eluting Balloons Catheters Market

  • 25.1. Canada Drug Eluting Balloons Catheters Market Overview
  • 25.2. Canada Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Eluting Balloons Catheters Market

  • 26.1. South America Drug Eluting Balloons Catheters Market Overview
  • 26.2. South America Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Eluting Balloons Catheters Market

  • 27.1. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Eluting Balloons Catheters Market

  • 28.1. Middle East Drug Eluting Balloons Catheters Market Overview
  • 28.2. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Eluting Balloons Catheters Market

  • 29.1. Africa Drug Eluting Balloons Catheters Market Overview
  • 29.2. Africa Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Eluting Balloons Catheters Market Competitive Landscape And Company Profiles

  • 30.1. Drug Eluting Balloons Catheters Market Competitive Landscape
  • 30.2. Drug Eluting Balloons Catheters Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic PLC
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Becton Dickinson and Company
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Koninklijke Philips NV
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Boston Scientific Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Drug Eluting Balloons Catheters Market Other Major And Innovative Companies

  • 31.1. B Braun Melsungen Aktiengesellschaft
  • 31.2. Terumo Corporation
  • 31.3. Cook Medical LLC
  • 31.4. Lepu Medical Technology Co. Ltd.
  • 31.5. Meril Life Sciences Pvt. Ltd.
  • 31.6. MicroPort Scientific Corporation
  • 31.7. BIOTRONIK SE & Co. KG
  • 31.8. Acotec Scientific Co. Ltd.
  • 31.9. Cordis Corporation
  • 31.10. Biosensors International Group Ltd.
  • 31.11. Zylox-Tonbridge Medical Technology Co. Ltd.
  • 31.12. Mermaid Medical AS
  • 31.13. Hexacath Limited
  • 31.14. Zhejiang Barty Medical Technology Co. Ltd.
  • 31.15. Cardionovum GmbH

32. Global Drug Eluting Balloons Catheters Market Competitive Benchmarking

33. Global Drug Eluting Balloons Catheters Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drug Eluting Balloons Catheters Market

35. Drug Eluting Balloons Catheters Market Future Outlook and Potential Analysis

  • 35.1 Drug Eluting Balloons Catheters Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Drug Eluting Balloons Catheters Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Drug Eluting Balloons Catheters Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer